{"prompt": "['abbvie', 'Rovalpituzumab Tesirine', 'M16-298 Protocol Amendment 4', 'EudraCT 2016-003503-64', 'thickness). The measurement of these lesions is potentially non-reproducible; therefore', 'providing this default value will prevent false responses or progression based upon', 'measurement error.', 'Evaluation of Non-Target Lesions', 'Complete Response (CR):', 'The disappearance of all non-target lesions and normalization of tumor marker level. All', 'lymph nodes must be non-pathological in size (<10 mm short axis).', 'Non-CR/Non-PD:', 'Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker level', 'above the normal limits.', 'Progressive Disease (PD):', 'Unequivocal progression of existing non-target lesions.', \"In this setting, to achieve 'unequivocal progression' on the basis of non-target disease,\", 'there must be an overall level of substantial worsening in non-target disease such that,', 'even in the presence of SD or PR in target disease, the overall tumor burden has increased', \"sufficiently to merit discontinuation of therapy. A modest 'increase' in the size of one or\", 'more non-target lesions is usually not sufficient to qualify for unequivocal progression', 'status. The designation of overall progression solely on the basis of change in non-target', 'disease in the face of SD or PR of target disease will therefore be extremely rare.', 'New Lesions', 'The appearance of new malignant lesions denotes disease. While there are no specific', 'criteria for the identification of new radiographic lesions, the findings of a new lesion', 'should be unequivocal; i.e., not attributable to differences in scanning technique, timing of', 'scanning, phase of contrast administration, change in imaging modality or finding thought', '135']['abbvie', 'Rovalpituzumab Tesirine', 'M16-298 Protocol Amendment 4', 'EudraCT 2016-003503-64', \"to represent something other than tumor (e.g., some 'new' bone lesions may be simply\", 'healing or flare of pre-existing lesions). A lesion identified on a follow-up study in an', 'anatomical location that was not scanned at baseline is considered a new lesion and will', 'indicate disease progression.', 'If a new lesion is equivocal (e.g., too small to measure), continued therapy and follow-up', 'evaluation will clarify if it represents truly new disease. If repeat scans confirm there is a', 'new lesion, then progression should be declared using the date of the initial scan.', '136']['abbvie Rovalpituzumab Tesirine', 'M16-298 Protocol Amendment 4', 'EudraCT 2016-003503-64', 'Appendix H.', 'CTCAE V 4.0 Grading of Relevant AEs', 'Group', 'Adverse Event', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Serosal', 'Ascites', 'Asymptomatic; clinical', 'Symptomatic; medical', 'Severe symptoms;', 'Life-threatening', 'Effusions', 'or diagnostic', 'intervention indicated', 'invasive intervention', 'consequences; urgent', 'observations only;', 'indicated', 'operative intervention', 'intervention not indicated', 'indicated', 'Definition: A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity.', 'Pericardial effusion', '-', 'Asymptomatic effusion size', 'Effusion with', 'Life-threatening', 'small to moderate', 'physiologic', 'consequences; urgent', 'consequences', 'intervention indicated', 'Definition: A disorder characterized by fluid collection within the pericardial sac, usually due to inflammation.', 'Pericardial tamponade', '-', 'Life-threatening', 'consequences; urgent', 'intervention indicated', 'Definition: A disorder characterized by an increase in intrapericardial pressure due to the collection of blood or fluid in the pericardium.', 'Pleural effusion', 'Asymptomatic; clinical', 'Symptomatic; intervention', 'Symptomatic with', 'Life-threatening', 'or diagnostic', 'indicated (e.g., diuretics or', 'respiratory distress and', 'respiratory or', 'observations only;', 'limited therapeutic', 'hypoxia; surgical', 'hemodynamic', 'intervention not indicated', 'thoracentesis)', 'intervention including', 'compromise; intubation or', 'chest tube or pleurodesis', 'urgent intervention', 'indicated', 'indicated', 'Definition: A disorder characterized by an increase in amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough', 'and marked chest discomfort.', 'Capillary leak syndrome', '-', 'Symptomatic; medical', 'Severe symptoms;', 'Life-threatening', 'intervention indicated', 'intervention indicated', 'consequences; urgent', 'intervention indicated', '137']\n\n###\n\n", "completion": "END"}